Skip to main content

Table 2 DKA single vs recurrent episodes

From: Recurrent DKA results in high societal costs – a retrospective study identifying social predictors of recurrence for potential future intervention

 

DKA recurrence

Multivariate analysis

n, number of patients with DKA recurrence/N, total number of patients in category, (%)

OR, (95% CI)

P-value

Race

 White

7/95, (7%)

1, (-)

0.0001

 African American

26/119, (22%)

4.63, (1.82–13.29)

 Other ethnicity

15/51 (29%)

8.55, (2.93–27.94)

Age

 18-36y

27/89, (30%)

1, (-)

0.11

 37-52y

14/89, (16%)

0.48, (0.19–1.16)

 53-99y

7/87, (8%)

0.37, (0.12–0.99)

Type 1 DM

 No

17/149, (11%)

1, (-)

0.04

 Yes

31/116, (27%)

2.39, (1.06–5.47)

Ever homeless

 No

26/194, 13%)

1, (-)

0.03

 Yes

22/71, (31%)

2.45, (1.11–5.44)

Drug abuse

 No

31/224, (14%)

1, (-)

0.009

 Yes

17/41, (41%)

3.22, (1.34–7.84)

eGFR < 30 ml/hr

 No

42/247, (17%)

1, (-)

0.12

 Yes

6/18, (33%)

2.62, (0.77–8.56)